Skip to content

The effect of dialectical behavior therapy in autism spectrum patients with suicidality and/or self destructive behaviour: a multi-site randomized controlled trial.

The effect of dialectical behavior therapy in autism spectrum patients with suicidality and/or self destructive behaviour: a multi-site randomized controlled trial. - DIASS

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON53092
Enrollment
128
Registered
2018-03-16
Start date
2018-09-02
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

autism suicidality and destructive behavior

Interventions

*Dialectical behaviour therapy* will be compared with *treatment as usual*. In the DBT condition, patients combines weekly individual cognitive behavioral psychotherapy sessions given by primary the

Sponsors

Vrije Universiteit
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: 1) age between 18 and 65 years 2) Meets DSM V criteria for autism spectrum disorder 3) Suicidal and / or self destructive behavior have shown in year before starting treatment 4) Sufficient mastery of the Dutch language 5) Outpatient

Exclusion criteria

Exclusion criteria: 1) IQ

Design outcomes

Primary

MeasureTime frame
The first objective is to asses the effect of a short term DBT treatment program (26 weeks) versus treatment as usual, in terms of reduction of suicidal and/or self-harming behaviour in adult patients with autism

Secondary

MeasureTime frame
Secondly, the effects of DBT treatment are determined on anxiety and social performance, depression, core symptoms of ASD, quality of life and cost-effectiveness and cost-utility. Thirdly, predictors, moderators, and mediators for treatment success will be explored. These include emotion regulation; strength of the therapeutic alliance; difficulties engaging in goal-directed behaviours; demographic characteristics and alexithymia

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)